NCT05598775View on ClinicalTrials.gov

Long-Term Safety Study of CTX0E03 in Subjects Who Completed PISCES III Study

Enrolling by invitationOBSERVATIONAL

Enrollment

9

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

November 1, 2026

Study Completion Date

December 31, 2026

Conditions

Ischemic Stroke

Interventions

OTHER

Non Interventional long term safety follow up

Non Interventional long term safety follow up

Trial Locations (1)

26505

Amy Miller, RPh, PharmD, Morgantown

All Listed Sponsors

lead

ReNeuron Limited

INDUSTRY